KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy.
| Image |  |
|---|---|
| Description | scientific article published on 23 October 2015 |
| Author/s |
author: Susan Branford David T Yeung Agnes Yong Deborah L. White |
| Publication date | October 23, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |